Lv1
10 积分 2021-08-05 加入
Factors influencing the development of cutaneous squamous cell carcinoma in patients on BRAF inhibitor therapy
26天前
已完结
Dabrafenib: a new opportunity for the treatment of BRAF V600-positive melanoma
26天前
已完结
Cutaneous Side Effects of Single Versus Combined BRAF Inhibitors: A Comment to Erfan et al
26天前
已关闭
Clinical management of cutaneous adverse events in patients on targeted anticancer therapies and immunotherapies: a national consensus statement by the Spanish Academy of Dermatology and Venereology and the Spanish Society of Medical Oncology
1个月前
已完结
Chemotherapy-Induced Reticulate Hypermelanosis: A Systematic Review of Clinical Features, Causative Agents, and Management Outcomes
1个月前
已完结
Treatment of metastatic colorectal cancer with BRAF V600E mutation: A multicenter real-world study in China
1个月前
已完结
Partial response to crizotinib + regorafenib + PD-1 inhibitor in a metastatic BRAF V600EMT colon cancer patient with acquired C-MET amplification and TPM4-ALK fusion: a case report
1个月前
已完结
Patterns in genomic mutations among patients with early-onset colorectal cancer: an international, multicohort, observational study
1个月前
已完结
Paradigmenwechsel in der Erstlinientherapie des BRAF-V600E-mutierten metastasierten kolorektalen Karzinoms
2个月前
已完结
The involvement of major signaling pathways in metastasis of colorectal cancer and the therapeutic application of their inhibitors
2个月前
已完结
皖公网安备34019202002308
